The Oncology Institute jump-starts next wave of value-based care

TOI, backed by Havencrest, ROCA and M33, reveals a SPAC transaction that sources say could spark further investment around value-based specialty healthcare groups.

BySarah Pringle

30 June 2021•7 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Healthcare Featured Top Stories

The Oncology Institute jump-starts next wave of value-based care

ROCA Partners

Deerfield

Havencrest Capital Management

M33 Growth

TA Associates

Related articles